Scientific Culture Unit The training, free of charge and aimed at the staff of the Puerta de Hierro-Segovia Health Research Institute (IDIPHISA), will cover different tools and formats for communicating science in a rigorous, accessible and attractive way. The Science Culture Unit…
Unit of Scientific Culture and Innovation A study coordinated by researchers from the Puerta de Hierro-Segovia Research Institute in Arana, published in Pharmacological Research, has evaluated the blood levels of pembrolizumab as a potential prognostic biomarker in cancer patients…
Unit of Scientific Culture and Innovation The renewal by the European Commission represents recognition of the work and commitment of IDIPHISA to improve working conditions, the working environment and the professional development of staff…
Unit of Scientific Culture and Innovation An international and multicenter study involving the Puerta de Hierro Hospital, published in JAMA Oncology, analyzes the long-term evolution of patients with recurrent ovarian cancer who achieved a…
Unit of Scientific Culture and Innovation The Spanish Group on Lung Cancer presented the results of the DUMAS clinical trial at the World Conference on Lung Cancer on September 14th; this study evaluates a new strategy to treat lung…
An international study involving the Puerta de Hierro University Hospital in Majadahonda, published in the journal Nature, evaluates the presence and evolution of tumor and genomic markers during neoadjuvant immunotherapy in patients with lung cancer…
On 30 June, the Faculty of Medicine of the Universidad Autónoma de Madrid (UAM) held a collaborative event with the Health Research Institutes of the hospitals linked to the UAM. The event aimed to strengthen the…
Scientific Culture and Innovation Unit A team of researchers from IDIPHISA–Hospital Universitario Puerta de Hierro, led by Marina Pérez-Aguilera and Lucía Pedrosa from the Lymphoma Research Group headed by Margarita Sánchez-Beato, has published a new study in collaboration…
Scientific Culture and Innovation Unit Hospital Universitario Puerta de Hierro Majadahonda is taking part in two clinical studies seeking to develop two new antibody conjugates for the treatment of advanced ovarian cancer. Both Phase I trials, GSK 300163…
